Currently, suppliers should have at least heard the mention of the next NCPDP 2023 standard, which is in force now and will be required by January 1, 2027. NCPDP (the new National Council for Programs on Prescription Medicines) is the problem of problem solving for health care, and the new transparency standard. So what is the standard resolution for and what can suppliers are waiting for?
As a technology professional working alongside suppliers daily to help them prepare for this transition, I see four key themes in the NCPDP 2023 standard:
1. Security and clarity with data standardization: With New GIS standards (instruction instruction), for example, drug instructions will be clearer and less prone to interpretation. They also increase more structured data capacity, which allows automatic learning and AI automation solutions.
2. Association of communication between providers, patients and pharmacies: New standards for common practices such as pharmacy transfers to pharmacy prescription will improve coordination and reduce administrative charges.
3. Simplification of processes for prior authorization and support for specialized medicine: Improved workflows will accelerate the examination and approvals to get patients necessary for patients faster.
4. Better interoperability: Automated data exchange can ensure that the data is structured to be analyzed with AI tools, which will ultimately lead to health care and better care.
The common theme: the creation of structured unstructured data. Currently, many data on health care is not structured – such as sticking notes handwritten in a file – which makes it difficult to capture and analyze. Structured data can be analyzed by people or machines, which makes it more useful. As AI permeates medicine, structured data will be the basis of innovation.
Here are the most visible changes that suppliers should expect:
- SIG structured to reduce the ambiguity of medicine instructions. Free text instructions like “take two tablets at bedtime” have not been structured, although most suppliers have followed a similar format. As part of the NCPDP 2023 standard, the structured SIG provides a standardized format for the electronic structuring of patient instructions for prescriptions.
- Improvement of RX Transfer processes and cancel RX. As prescription prices have become more transparent, RX transfers and cancellations have become more common. 2023 The NCPDP standard adds new standard transactions for these processes, eliminating manual steps such as fax, looking for the acceleration of these transactions for patients.
- More automation linked to medical and. Membership of drugs is always a major concern for providers. The NCPDP 2023 standard introduces new features aimed at improving it, including one that automates recharge work flows by allowing proactive replenishments and triggered by the system, in particular in long -term care – reducing manual intervention, therapy gaps and timely pharmacies between prescribers and pharmacies.
How and when did these changes come into force?
Service providers must be ready to move on to the new standard by January 1, 2027. The 2017-20071 standard will cease to be supported on January 1, 2028. It may seem long from now on, but health care providers and technology providers may – and should – start to prepare now.
Most of the transition burden concerns technology suppliers, who are already working hard to update their back-set in favor of the NCPDP 2023 standard. If you have not yet heard of your supplier, check and ask for a calendar.
During this transition, many suppliers will take the opportunity to search for new workflow experiences to maximize new features while taking some technical steps to update the user interface and APIs. The start of the upgrade process will soon leave time to make the staff competent with the changes, and for tests and certification long before the end of the 2017 NCPDP standard.
By prioritizing the necessary updates to support the new standard, suppliers will be better placed to use the most recent technology and the largest optimization for their workflow and patient care.
(The author wishes to thank Larry Gillette and David Rossi for their contributions to this room.)
Photo: Ronnachaipark, Getty Images
Julian Herbert began his career in the development of technological products as a commercial analyst focused on electronic commerce in the semiconductor industry. After his curiosity, he became a management consultant at Deloitte and led disinvestment and integration commitments into a variety of industries, including pharmacy and biotechnology. He then returned to the development of products and electronic commerce on Amazon, launching automatic learning solutions for third-party sellers on the platform. Julian was also responsible for directing the development of products for AWS startups, building its first range of micro-cut products.
At Dosespot, Julian directs the innovation of products, helping the company to develop and provide a secure and reliable e-presentation technology and software integrations in several health care markets. Julian is from Louisiana and graduated from the Southern University promotion major in Baton Rouge with a BS in computer science. He also has an MBA of the Ross School of Business of the University of Michigan, focusing on strategy and entrepreneurship.
This message appears through the Medcity influencers program. Anyone can publish their point of view on business and innovation in health care on Medcity News through Medcity influencers. Click here to find out how.
:max_bytes(150000):strip_icc()/VWH-GettyImages-1359074648-21a4365b9f8c4608a4a3fcfdd9764391.jpg?w=390&resize=390,220&ssl=1 "5 foods with more benefits for intestinal health than sauerkraut")
:max_bytes(150000):strip_icc()/Health-cheese-recall-main-d1ab0ef4759846fe92794f858226a25f.png?w=390&resize=390,220&ssl=1 "Products sold in these 9 states may contain listeria, the FDA warns")